Skip to main content
Download PDF

Adverse postoperative outcomes in elderly patients with sarcopenia

BMC Geriatrics volume 24, Article number: 561 (2024) Cite this article

Abstract

Purpose

No study has compared 30-day and 90-day adverse postoperative outcomes between old-age patients with and those without sarcopenia.

Patients and methods

We categorize elderly patients receiving major surgery into two groups according to the presence or absence of preoperative sarcopenia that were matched at a 1:4 ratio through propensity score matching (PSM). We analyzed 30-day or 90-day adverse postoperative outcomes and mortality in patients with and without sarcopenia receiving major surgery.

Results

Multivariate logistic regression analyses revealed that the patients with preoperative sarcopenia were at significantly higher risk of 30-day postoperative mortality (adjusted odds ratio [aOR]. = 1.25; 95% confidence interval [CI]. = 1.03–1.52) and 30-day major complications such as postoperative pneumonia (aOR = 1.15; 95% CI = 1.00-1.40), postoperative bleeding (aOR = 2.18; 95% CI = 1.04–4.57), septicemia (aOR = 1.31; 95% CI = 1.03–1.66), and overall complications (aOR = 1.13; 95% CI = 1.00-1.46). In addition, surgical patients with sarcopenia were at significantly higher risk of 90-day postoperative mortality (aOR = 1.50; 95% CI = 1.29–1.74) and 90-day major complications such as pneumonia (aOR = 1.27; 95% CI = 1.10–1.47), postoperative bleeding (aOR = 1.90; 95% CI = 1.04–3.48), septicemia (aOR = 1.52; 95% CI = 1.28–1.82), and overall complications (aOR = 1.24; 95% CI = 1.08–1.42).

Conclusions

Sarcopenia is an independent risk factor for 30-day and 90-day adverse postoperative outcomes such as pneumonia, postoperative bleeding, and septicemia and increases 30-day and 90-day postoperative mortality among patients receiving major surgery.

Condensed abstract

No study has compared 30-day and 90-day adverse postoperative outcomes between patients with and those without sarcopenia. We conducted a propensity score?matched (PSM) population-based cohort study to investigate the adverse postoperative outcomes and mortality in patients undergoing major elective surgery with preoperative sarcopenia versus those without preoperative sarcopenia. We demonstrated that sarcopenia is an independent risk factor for 30-day and 90-day adverse postoperative outcomes, such as postoperative pneumonia, bleeding, septicemia, and mortality after major surgery. Therefore, surgeons and anesthesiologists should attempt to correct preoperative sarcopenia, swallowing function, and respiratory muscle training before elective surgery to reduce postoperative complications that contribute to the decrease in surgical mortality.

Peer Review reports

Introduction

Sarcopenia is defined as the progressive and generalized loss of skeletal muscle mass and strength with a risk of adverse outcomes, such as physical disability, poor quality of life, and even death [1]. Lifestyle, physical inactivity, malnutrition, and chronic diseases (e.g., osteoporosis and metabolic diseases) are all risk factors for sarcopenia [2,3,4]. Currently, the pathogenesis of sarcopenia is unclear. However, sarcopenia may be related to genetics, nutritional deficiencies, neuromuscular function, hormones, autophagy, mitochondrial abnormalities, and gut flora [5, 6]. Sarcopenia not only increases the fall rate, disability rate, hospitalization rate, surgical complication rate, and even mortality but also affects the occurrence, development, and prognosis of various diseases [7]. However, research on sarcopenia is currently in the exploratory stage, and the association of preoperative sarcopenia with surgery is unclear.

The mass and strength of skeletal muscles are affected by various factors, such as age, gender, underlying diseases, dietary habits, and exercise, and can reflect the overall functional status [8]. In general, the prognosis of surgical patients is closely related to the functional status [9]. Patients with sarcopenia, as a special group, often exhibit low physical function, and they may be at an increased risk of postsurgical complications [10, 11]. Moreover, sarcopenia can lead to a decrease in skeletal muscle and the weakening of respiratory and swallowing muscles, thereby resulting in atelectasis, pneumonia, dysphagia, and malnutrition [12]. These aforementioned factors may increase postoperative complications and mortality, prolong hospital stay, affect quality of life, and increase health-care costs [13]. Therefore, surgeons and anesthesiologists should pay increased attention to patients with sarcopenia, as a potential high-risk group for adverse postoperative outcomes.

The influence of preoperative sarcopenia on the prognosis of major postoperative outcomes is unclear. The findings of previous studies on the association of sarcopenia with adverse postoperative outcomes and mortality are conflicting, and studies with an adequate sample size, clear definition of sarcopenia, and satisfactory results are scant [13,14,15,16]. Therefore, large-scale clinical research should be conducted on the prognosis of postoperative outcomes in patients with sarcopenia by utilizing a real-world database. Therefore, we conducted a comparative study through PSM to estimate the effects of preoperative sarcopenia on the outcomes of elective surgery.

Patients and methods

Data sources

We used data from January 2016 to December 2019 from Taiwan’s National Health Insurance (NHI) Research Database (NHIRD). The follow-up duration was from the index date to December 31, 2020. The NHIRD contains registration files and the original claims data of all NHI beneficiaries (i.e., approximately 27.38 million individuals). All NHIRD data, which are encrypted to ensure beneficiaries’ privacy, include detailed outpatient and inpatient claims information such as patient identification number; birth date; sex; diagnostic codes according to International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) and International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM); treatment information; medical costs; dates of hospital admission and discharge; and date of death [17,18,19,20,21]. All data sets were interlinked using patient identification numbers. Our protocols were reviewed protocols were reviewed and approved by the Institutional Review Board of Tzu-Chi Medical Foundation (IRB109-015-B).

Ethics

I would like to clarify that informed consent was waived in our study. This decision was made in accordance with the Personal Information Protection Act, as the data sets used in our research fall under its provisions.

Participant selection

We selected 254,222 elderly patients aged ≥ 60 years who underwent major elective inpatient surgery; these old-age patients required general, epidural, or spinal anesthesia and hospitalization for more than 1 day between 2016 and 2019 in Taiwan. The evaluation of CT scans was limited to the 12-month preoperative period. Among the selected patients, 12,158 patients with a diagnosis of sarcopenia and 242,067 without a diagnosis of sarcopenia were categorized into the sarcopenia and nonsarcopenia groups, respectively (Supplemental Table 1). Before 2016, because of a lack of consensus regarding the definition of sarcopenia, a variety of diagnostic criteria were used [22]. In October 2016, the US Centers for Disease Control and Prevention formally recognized sarcopenia as a disease and coded it as M62.84 in ICD-10-CM [23]. We defined sarcopenia according the ICD-10-CM code after 2016 [17]. At least two claims for patients with a principal diagnosis of sarcopenia within the 12-month preoperative period were defined as the criteria for sarcopenia diagnosis. In Taiwan, sarcopenia was coded according to the results of a previous Taiwan study [24]; sarcopenia was defined as the skeletal muscle mass index (SMI) of 2 standard deviations or more below the normal sex-specific mean values for young persons. The date of onset of diabetes was regarded as the index date. The SMI was calculated using the following formula: SMI = L3 skeletal muscle cross-sectional area (cm2)/height2(m2), which was measured from computed tomography images [25].

PSM and covariates

After adjustment for confounders, we used a multivariate logistic regression model to assess 30-day or 90-day postoperative complications onset from the index date (surgical date) in patients with and without preoperative sarcopenia. To reduce the effects of potential confounders when comparing adverse postoperative outcomes between the sarcopenia and nonsarcopenia groups, we matched all patients through PSM according to the following variables: age, sex, income levels, urbanization, coexisting medical conditions, hospital level, type of anesthesia, ASA score, and surgical type (Table 1). We matched the cohorts at a ratio of 1:4 using a greedy matching method, and the covariates were matched within a caliper with a propensity score of 0.2 [26]. Comorbidities were determined according to ICD-9-CM codes in the main diagnosis records of inpatients or were defined if the number of outpatient visits was ≥ 2 within 1 year. Comorbidities that occurred 2 years before the index date were included in this study.

Table 1 Characteristics of Surgical Patients With and Without Preoperative Sarcopenia (After Propensity Scores Were Matched)
Full size table

Continuous variables are presented as means ± standard deviations where appropriate. A PSM ratio of 1:4 was used for the preoperative sarcopenia and nonsarcopenia groups; this ratio is commonly used to select controls with identical background covariates to minimize the differences among participants (we considered using controls based on previous studies) [27,28,29,30,31,32]. A multivariate logistic regression model was used to analyze postoperative complications in surgical patients with and without preoperative sarcopenia [33]. Using multivariate logistic regression analysis, we calculated odd ratios (ORs) with 95% confidence intervals (CIs) to determine whether preoperative sarcopenia is a potential independent predictor of 30-day or 90-day postoperative complications.

Outcome measures

Eight major postoperative complications were monitored [28].: acute myocardial infarction, acute renal failure, deep-wound infection pneumonia, postoperative bleeding, pulmonary embolism, septicemia, and stroke. In our study, we utilized the Clavien Dindo classification system to categorize and describe postoperative complications, focusing on Grade 2 or higher complications [34]. The primary outcomes of this study were the complications and subsequent overall in-hospital mortality within 30 days after index surgery [27,28,29,30,31,32]. Studies have suggested that events recorded within 90 days of surgery are also postoperative complications [35,36,37,38,39].

Data analysis

We used χ2 tests to analyze the descriptive parameters of demographic characteristics and coexisting medical conditions in the comparison of postoperative complications and death rates of patients with and without preoperative sarcopenia. Continuous variables were analyzed using t tests to compare the differences between patients with sarcopenia and controls. Multivariate logistic regression was used to analyze 30-day and 90-day postoperative complications and mortality between surgical patients with or without sarcopenia through the calculation of the adjusted ORs (aORs) with 95% CIs, with adjustment for age, sex, income level, urbanization, coexisting medical conditions, hospital level, type of anesthesia, ASA score, and surgical type. The logistic regression model’s goodness-of-fit was comprehensively assessed using both the Hosmer-Lemeshow test and the Omnibus test. The Hosmer-Lemeshow test evaluated the agreement between observed and expected outcomes across subgroups, while the Omnibus test assessed the overall significance of the model. These model fit assessments, including the results of the Hosmer-Lemeshow test and Omnibus test, ensured the validity and appropriateness of our logistic regression model. The statistical analysis software program V.9.4 (SAS Institute, Cary, North Carolina, USA) was used for data analyses; the differences between the groups were considered significant if two-sided P values were < 0.05.

Results

Study cohort

The data of 60,790 surgical patients (i.e., 12,158 and 48,632 in the sarcopenia and nonsarcopenia groups, respectively) were included in this study for further analysis; their characteristics are listed in Table 1. After frequency matching, the between-group differences in age, sex, income levels, urbanization, coexisting medical conditions, hospital levels, types of anesthesia, ASA scores, and surgical types were nonsignificant. The confounders (before matching) in the sarcopenia group significantly differed from those in the nonsarcopenia group (p < .001; Supplemental Table 1). Compared with the nonsarcopenia group, the sarcopenia group had more individuals who were older, were female, had a low income, were rural residents, had more coexisting medical conditions, received surgery at medical centers, and received general anesthesia (Supplemental Table 1).

30-day or 90-day adverse postoperative outcomes

Patients with sarcopenia exhibited higher rates of 30-day postoperative complications, including postoperative pneumonia (1.18% vs. 0.93%; P = .0134), postoperative bleeding (0.09% vs. 0.04%; P = .0420), septicemia (0.76% vs. 0.53%; P = .0028), and overall complications (6.85% vs. 5.62%; P = .0162; Table 2). The 30-day postoperative mortality rates for surgical patients with and without sarcopenia were 1.21% and 0.94%, respectively (P = .0085). Moreover, patients with sarcopenia exhibited higher rates of 90-day postoperative complications, including postoperative pneumonia (2.23% vs. 1.63%; P < .0001), postoperative bleeding (0.13% vs. 0.07%; P = .0267), septicemia (1.50% vs. 0.92%; P < .0001), and overall complications (8.85% vs. 7.95%; P = .0111). The 90-day postoperative mortality rates for surgical patients with and without sarcopenia were 2.08% and 1.38%, respectively (P < .0001).

Table 2 Adverse postoperative outcomes among matched surgical patients with and without preoperative sarcopenia
Full size table

Adjusted ORs and 95% CIs for 30-day or 90-day adverse postoperative outcomes

After adjustment for age, sex, income levels, urbanization, coexisting medical conditions, hospital levels, types of anesthesia, ASA scores, and surgical types, our multivariate logistic regression analyses revealed that surgical patients with preoperative sarcopenia were at significantly higher risk of 30-day postoperative mortality (aOR = 1.25; 95% CI 1.03 to 1.52) and 30-day major complications, including postoperative pneumonia (aOR = 1.15; 95% CI = 1.00-1.40), postoperative bleeding (aOR = 2.18; 95% CI = 1.04–4.57), septicemia (aOR = 1.31; 95% CI = 1.03–1.66), and overall complications (aOR = 1.13; 95% CI = 1.00-1.46). In addition, surgical patients with sarcopenia were at significantly higher risk of 90-day postoperative mortality (aOR = 1.50; 95% CI = 1.29–1.74) and 90-day major complications, including postoperative pneumonia (aOR = 1.27; 95% CI = 1.10–1.47), postoperative bleeding (aOR = 1.90; 95% CI = 1.04–3.48), septicemia (aOR = 1.52; 95% CI = 1.28–1.82), and overall complications (aOR = 1.24; 95% CI = 1.08–1.42; Table 3).

Table 3 Adjusted ORs and 95% CIs for adverse postoperative outcomes associated with preoperative sarcopenia
Full size table

Kaplan–Meier 30-day or 90-day postoperative mortality and complications

Figure 1 illustrates the cumulative risks of 30-day or 90-day postoperative mortality and complications in matched patients with and without sarcopenia. The cumulative 30-day postoperative mortality was significantly higher in the sarcopenia group than in the nonsarcopenia group (P < .0001; Fig. 1A), and the cumulative overall 30-day postoperative complications were significantly higher in the sarcopenia group than in the nonsarcopenia group (P < .0001; Fig. 1B). Moreover, the Kaplan–Meier curves revealed that the cumulative 90-day postoperative mortality and overall complications were significantly lower in the sarcopenia group than in the nonsarcopenia group (P < .0001; Fig. 2).

Fig. 1
figure 1

Kaplan–Meier Estimates of 30-d Postoperative Mortality and 30-d Postoperative Complications Among Surgical Patients With and Without Sarcopenia. (A) 30-d Postoperative Mortality; (B) 30-d Overall Postoperative Complications

Full size image
Fig. 2
figure 2

Kaplan–Meier Estimates of 90-d Postoperative Mortality and 90-d Postoperative Complications Among Surgical Patients With and Without Sarcopenia. (A) 90-d Postoperative Mortality; (B) 90-d Overall Postoperative Complications

Full size image

Discussion

Clinically, many patients with sarcopenia experience various challenges and severe complications of surgery [40]. However, the association of preoperative sarcopenia with adverse postoperative outcomes and mortality is unclear [13,14,15,16]. To the best of our knowledge, the present study is the first and the largest PSM-based comparative study on 30-day and 90-day adverse postoperative outcomes and mortality among patients with and without preoperative sarcopenia. This retrospective, real-world data-derived, population-based PSM cohort study revealed that preoperative existing sarcopenia is an independent risk factor for 30-day and 90-day adverse postoperative outcomes, such as postoperative pneumonia, postoperative bleeding, and septicemia, and preoperative sarcopenia is associated with increased 30-day and 90-day postoperative mortality among patients receiving major surgery. Multivariate logistic regression analyses revealed that surgical patients with preoperative sarcopenia were at significantly higher risk of 30-day postoperative mortality (aOR = 1.25; 95% CI = 1.03–1.52) and 30-day major complications, including postoperative pneumonia (aOR = 1.15; 95% CI = 1.00-1.40), postoperative bleeding (aOR = 2.18; 95% CI = 1.04–4.57), septicemia (aOR = 1.31; 95% CI = 1.03–1.66), and overall complications (aOR = 1.13; 95% CI = 1.00-1.46). In addition, surgical patients with sarcopenia were at significantly higher risk of 90-day postoperative mortality (aOR = 1.50; 95% CI = 1.29–1.74) and 90-day major complications, including postoperative pneumonia (aOR = 1.27; 95% CI = 1.10–1.47), postoperative bleeding (aOR = 1.90; 95% CI = 1.04–3.48), septicemia (aOR = 1.52; 95% CI = 1.28–1.82), and overall complications (aOR = 1.24; 95% CI = 1.08–1.42). Our results provide valuable comprehensive information on postoperative complications, especially postoperative pneumonia, postoperative bleeding, and postoperative septicemia, among patients with sarcopenia receiving surgery. Establishing a comprehensive protocol to prevent the aforementioned postoperative complications that contribute to surgical mortality can be valuable to future research.

Several reports have indicated similar outcomes [41,42,43,44], suggesting an association between preoperative sarcopenia and increased postoperative complications [41,42,43,44]. In our extensive investigation, we explored the impact of preoperative sarcopenia on postoperative outcomes within a cohort of 254,222 elderly patients (≥ 60 years) undergoing major elective inpatient surgery in Taiwan between 2016 and 2019. Utilizing Taiwan’s NHIRD, which includes detailed claims data for approximately 27.38 million individuals, our study stands out for its large cohort size, facilitating robust statistical analyses. Unlike earlier studies that employed diverse diagnostic criteria for sarcopenia, our research defined sarcopenia post-2016 using the ICD-10-CM code M62.84 and incorporated specific criteria based on the SMI derived from CT scans. This nuanced approach allows for a more precise identification of sarcopenic patients. Furthermore, our study employed PSM and multivariate logistic regression to account for potential confounders, ensuring a meticulous analysis of 30-day and 90-day postoperative complications. The investigation of eight major complications, including acute myocardial infarction, acute renal failure, deep-wound infection pneumonia, postoperative bleeding, pulmonary embolism, septicemia, and stroke, adds granularity to the understanding of the outcomes. Furthermore, the concentration on individuals aged 60 and above, along with the meticulous matching of different surgical procedures through PSM, distinguishes our approach. Unlike previous studies primarily focusing on specific surgical types, such as cardiac or abdominal surgery [43, 44], our research expands the scope and enhances external validity due to a larger and more diverse sample [41,42,43,44]. Consequently, our conclusions elucidate a higher incidence of surgical complications among elderly individuals with sarcopenia, providing unique insights beyond the existing literature. Importantly, we extend our analysis beyond the conventional 30-day acute complications to include 90-day subacute complications, a novel contribution to the field. This study significantly advances our understanding of the intricate relationship between sarcopenia and postoperative outcomes, making a substantial and novel addition to the existing literature [41,42,43,44]. Our investigation not only scrutinizes acute complications within the conventional 30-day timeframe but extends its analysis to encompass subacute complications occurring within 90 days—a novel aspect absent in prior literature [41,42,43,44]. This extended timeframe provides a more comprehensive understanding of the postoperative complications associated with sarcopenia in the elderly, offering unique insights and a substantial addition to the existing literature.

The primary endpoints of our study were centered on complications and overall in-hospital mortality within 30 days following the index surgery, as supported by relevant literature [27,28,29,30,31,32]. Recognizing that postoperative events extend beyond the traditional 30-day window, recent studies have advocated for an extended observation period of 90 days to capture a more comprehensive spectrum of postoperative complications [35,36,37,38,39]. Specifically, the 90-day postoperative mortality metric has gained prominence as a robust measure of surgical quality, particularly for procedures involving the digestive tract or the head and neck [35,36,37,38,39]. Given the evolving understanding of the prolonged impact of surgery, we designated 90-day postoperative complications as a primary outcome in our study. This timeframe allows for a nuanced assessment of acute and subacute surgical complications, providing a more comprehensive perspective on patient outcomes. To maintain consistency with established practices and enhance comparability with prior research, we adhered to the definition of 30-day and 90-day in-hospital postoperative mortality as utilized in previous studies [27, 29,30,31,32, 35,36,37,38,39]. Consequently, patients who succumbed on the 91st day or later post-hospitalization were considered alive in our study, and those who died outside the hospital within 90 days were not included in the mortality outcome. In conclusion, the choice of assessing 30- and 90-day postoperative complications aligns with contemporary views on capturing the continuum of surgical outcomes, offering a more nuanced understanding of acute and subacute complications associated with the procedures under investigation.

A patient with sarcopenia receiving elective surgery is a patient with certain systemic imbalances and a worse biological reserve, which may contribute to a poor postoperative prognosis; this finding is consistent with a previous study finding [45]. Moreover, many risk factors are closely related to sarcopenia, for example, increasing age, malnutrition, alcoholism, smoking, insomnia, and chronic diseases, which often affect surgical prognosis and cause postoperative death [46,47,48]. Nevertheless, after matching for age, sex, income level, urbanization, coexisting medical conditions, hospital level, type of anesthesia, ASA score, and surgical type, sarcopenia is still an independent risk factor for 30-day and 90-day postoperative pneumonia, bleeding, septicemia, overall surgical complications, and mortality (Tables 2 and 3). In addition, not only the ORs of 30-day surgical complications and mortality but also the aORs of 90-day surgical complications and mortality were highly significant (Table 3; Fig. 2). The subacute surgical complications (90 d) may also be critical in patients with sarcopenia receiving surgery. Based on the outcomes of 30-day and 90-day surgical complications, patients with sarcopenia experience not only acute surgical complications but also subacute surgical complications after receiving elective surgery. The adverse outcomes of surgery in patients with sarcopenia do not alleviate even 30 days after surgery (Figs. 1 and 2).

The influence of sarcopenia on the prognosis of surgery is still unclear because of the small sample size, different definitions of sarcopenia, and different surgical types [10, 11, 13,14,15,16, 49,50,51,52,53,54,55]. Thus far, no study with sufficient sample size or with appropriate matching has investigated the association of sarcopenia with 30-day and 90-day surgical complications and mortality after elective surgery. To the best of our knowledge, this is the first study to use the latest definition of sarcopenia based on ICD-10 and to demonstrate 30-day and 90-day adverse outcomes of surgery in patients with sarcopenia and nonsarcopenia receiving elective surgery. According to our literature review, studies have not compared 30-day and 90-day surgical complications between sarcopenia and nonsarcopenia groups. Our study is the first to demonstrate that patients with sarcopenia exhibited significantly increased rates of 30-day and 90-day adverse outcomes, including postoperative pneumonia, bleeding, septicemia, and mortality after elective surgery.

Among various adverse outcomes after major surgery, postoperative septicemia is one of the key factors leading to the death of patients with sarcopenia [56,57,58,59]. Our findings indicated that the incidence of 30-day and 90-day postoperative septicemia was significantly higher among patients with sarcopenia than among those without sarcopenia (Tables 2 and 3). The high incidence of postoperative septicemia in sarcopenia patients receiving surgery can be attributed to low immunity compared with that of nonsarcopenia patients [60, 61]. Muscle fibers can produce cytokines and interleukins, inhibiting the secretion of tumor necrosis factor and mediating insulin resistance [62, 63]. Sarcopenia reduces cellular immune function, increases the level of proinflammatory factors, and increases the possibility of infection in the body [60, 61]. Moreover, the level of glutamine, which is an activator of lymphocytes and monocytes, is significantly reduced in patients with sarcopenia, thereby partly weakening their immunity [64]. Studies have suggested that sarcopenia may be one of the predictors of infection after colon cancer surgery [11].

Decreased immunity in patients with sarcopenia not only increases the possibility of postoperative infection but also increases the incidence of postoperative pneumonia [60, 61, 65]. In addition, patients with sarcopenia receiving surgery may experience difficulty in sputum removal and a high incidence of choking or aspiration pneumonia due to muscular weakness [66, 67]. Soma et al. reported that preoperative sarcopenia in patients with esophageal cancer increases the risk of postoperative respiratory disease [68]; this is consistent with our findings. The increase in postoperative pneumonia may be related to the decrease in skeletal muscle mass and the weakening of respiratory and swallowing muscles in patients with sarcopenia [66, 67]. Jain et al. demonstrated that short-term resistance exercise training and protein supplementation before surgery can increase the mass and strength of skeletal muscles and reduce fat content, thereby improving immunity and reducing the incidence of postoperative pulmonary complications [69]. Therefore, preoperative sarcopenia, swallowing function, and respiratory muscle training should be improved before elective surgery to decrease the incidence of postoperative pneumonia, other surgical complications, and mortality.

Our study discovered that patients with sarcopenia had a significantly increased incidence of 30-day and 90-day postoperative bleeding. To the best of our knowledge, no study has reported that sarcopenia directly alters the coagulation system; however, large retrospective studies have demonstrated that malnutrition can lead to postoperative bleeding in patients undergoing colorectal resection and pancreatic surgery, increase the risks of respiratory failure or infection, and even increase the mortality rate of patients [70, 71].

The present study used data from the NHIRD, which reliably records the detailed medical information of Taiwanese patients, and this database has been used in many high-quality studies [17, 20, 21, 27, 28]. Furthermore, a large PSM-based design was employed in the comparative study to maintain balance among the confounders of the case and control groups—all in the absence of bias (Table 1). However, this study has a few limitations. First, PSM cannot control factors that are not accounted for in the model, and it is predicated on an explicit selection bias of the factors that can be matched. Second, because all patients were enrolled from an Asian population, the corresponding ethnic susceptibilities in non-Asian populations are unclear. However, no significant differences in the postoperative adverse outcomes and mortality have been reported between Asian and non-Asian populations; the results should be cautiously extrapolated to non-Asian populations. Third, another limitation of this study pertains to the diagnosis of sarcopenia, which relies solely on the availability of the ICD code. Consequently, if an individual is unintentionally omitted from receiving the sarcopenia code, they are categorized as not having sarcopenia. We acknowledge that this approach may result in potential underestimation. Recognizing this limitation, we emphasize the importance of conducting further prospective studies to yield more accurate and comprehensive results in this area.

Conclusions

We demonstrated that sarcopenia is an independent risk factor for 30-day and 90-day adverse postoperative outcomes such as postoperative pneumonia, bleeding, septicemia, and mortality after elective surgery. Therefore, preoperative sarcopenia, swallowing function, and respiratory muscle training should be corrected before elective surgery to reduce the incidence of postoperative complications that contribute to the decrease in surgical mortality.

Data availability

The datasets essential for supporting the conclusions of this study are provided within the manuscript and its supplementary files.

Abbreviations

OR:

Odds ratio

aOR:

Adjusted odds ratio

CI:

Confidence interval

ICD-9-CM:

International Classification of Diseases, Ninth Revision, Clinical Modification

ICD-10-CM:

International Classification of Diseases, Tenth Revision, Clinical Modification

PSM:

Propensity score matching

NHIRD:

National Health Insurance Research Database

ASA:

American Society of Anesthesiology

SD:

Standard deviation

SMD:

Standardized mean difference

IQR:

Interquartile range

y:

Years-old

NHI:

National Health Insurance

SMI:

Skeletal muscle mass index

References

  1. Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyere O, Cederholm T, Cooper C, Landi F, Rolland Y, Sayer AA, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(1):16–31.

    Article  PubMed  Google Scholar 

  2. Choe HJ, Cho BL, Park YS, Roh E, Kim HJ, Lee SG, Kim BJ, Kim M, Won CW, Park KS, et al. Gender differences in risk factors for the 2 year development of Sarcopenia in community-dwelling older adults. J Cachexia Sarcopenia Muscle. 2022;13(3):1908–18.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Chen X, Hou L, Zhang Y, Dong B. Analysis of the prevalence of Sarcopenia and its risk factors in the Elderly in the Chengdu Community. J Nutr Health Aging. 2021;25(5):600–5.

    Article  CAS  PubMed  Google Scholar 

  4. Hwang J, Park S. Gender-specific risk factors and prevalence for Sarcopenia among Community-Dwelling Young-Old adults. Int J Environ Res Public Health 2022, 19(12).

  5. Ebadi M, Bhanji RA, Mazurak VC, Montano-Loza AJ. Sarcopenia in cirrhosis: from pathogenesis to interventions. J Gastroenterol. 2019;54(10):845–59.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Yin J, Lu X, Qian Z, Xu W, Zhou X. New insights into the pathogenesis and treatment of Sarcopenia in chronic heart failure. Theranostics. 2019;9(14):4019–29.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Janssen I. Influence of Sarcopenia on the development of physical disability: the Cardiovascular Health Study. J Am Geriatr Soc. 2006;54(1):56–62.

    Article  PubMed  Google Scholar 

  8. Lim JY, Frontera WR. Single skeletal muscle fiber mechanical properties: a muscle quality biomarker of human aging. Eur J Appl Physiol. 2022;122(6):1383–95.

    Article  CAS  PubMed  Google Scholar 

  9. Sindhar S, Kallogjeri D, Wildes TS, Avidan MS, Piccirillo JF. Association of Preoperative Functional Performance with outcomes after Surgical Treatment of Head and Neck Cancer: a clinical severity staging system. JAMA Otolaryngol Head Neck Surg. 2019;145(12):1128–36.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Sandini M, Patino M, Ferrone CR, Alvarez-Perez CA, Honselmann KC, Paiella S, Catania M, Riva L, Tedesco G, Casolino R, et al. Association between changes in body composition and Neoadjuvant Treatment for Pancreatic Cancer. JAMA Surg. 2018;153(9):809–15.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Feliciano EMC, Kroenke CH, Meyerhardt JA, Prado CM, Bradshaw PT, Kwan ML, Xiao J, Alexeeff S, Corley D, Weltzien E, et al. Association of Systemic Inflammation and Sarcopenia with Survival in Nonmetastatic Colorectal Cancer: results from the C SCANS study. JAMA Oncol. 2017;3(12):e172319.

    Article  PubMed  Google Scholar 

  12. Friedman J, Lussiez A, Sullivan J, Wang S, Englesbe M. Implications of Sarcopenia in major surgery. Nutr Clin Pract. 2015;30(2):175–9.

    Article  PubMed  Google Scholar 

  13. Wang H, Yang R, Xu J, Fang K, Abdelrahim M, Chang L. Sarcopenia as a predictor of postoperative risk of complications, mortality and length of stay following gastrointestinal oncological surgery. Ann R Coll Surg Engl. 2021;103(9):630–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Hendrickson NR, Mayo Z, Shamrock A, Kesler K, Glass N, Nau P, Miller BJ. Sarcopenia is associated with increased mortality but not complications following resection and reconstruction of sarcoma of the extremities. J Surg Oncol. 2020;121(8):1241–8.

    Article  PubMed  Google Scholar 

  15. Kim EY, Lee HY, Kim KW, Lee JI, Kim YS, Choi WJ, Kim JH. Preoperative computed tomography-determined Sarcopenia and Postoperative Outcome after surgery for Non-small Cell Lung Cancer. Scand J Surg. 2018;107(3):244–51.

    Article  CAS  PubMed  Google Scholar 

  16. Siegal SR, Dolan JP, Dewey EN, Guimaraes AR, Tieu BH, Schipper PH, Hunter JG. Sarcopenia is not associated with morbidity, mortality, or recurrence after esophagectomy for cancer. Am J Surg. 2018;215(5):813–7.

    Article  PubMed  Google Scholar 

  17. Sun MY, Chang CL, Lu CY, Wu SY, Zhang JQ. Sarcopenia as an independent risk factor for specific cancers: a propensity score-matched Asian Population-based Cohort Study. Nutrients 2022, 14(9).

  18. Huang YM, Chen WM, Chen M, Shia BC, Wu SY. Sarcopenia is an independent risk factor for severe Diabetic Nephropathy in Type 2 diabetes: a long-term Follow-Up propensity score-matched diabetes cohort study. J Clin Med 2022, 11(11).

  19. Tsai YH, Chen WM, Chen MC, Shia BC, Wu SY, Huang CC. Effect of Pre-Existing Sarcopenia on Oncological Outcomes for Oral Cavity Squamous Cell Carcinoma Undergoing Curative Surgery: A Propensity Score-Matched, Nationwide, Population-Based Cohort Study. Cancers (Basel) 2022, 14(13).

  20. Sun M, Chang CL, Lu CY, Zhang J, Wu SY. Effect of opioids on cancer survival in patients with chronic pain: a propensity score-matched population-based cohort study. Br J Anaesth. 2022;128(4):708–17.

    Article  CAS  PubMed  Google Scholar 

  21. Sun M, Lin JA, Chang CL, Wu SY, Zhang J. Association between long-term opioid use and cancer risk in patients with chronic pain: a propensity score-matched cohort study. Br J Anaesth. 2022;129(1):84–91.

    Article  CAS  PubMed  Google Scholar 

  22. Bijlsma AY, Meskers CG, Ling CH, Narici M, Kurrle SE, Cameron ID, Westendorp RG, Maier AB. Defining Sarcopenia: the impact of different diagnostic criteria on the prevalence of Sarcopenia in a large middle aged cohort. Age (Dordr). 2013;35(3):871–81.

    Article  CAS  PubMed  Google Scholar 

  23. Anker SD, Morley JE, von Haehling S. Welcome to the ICD-10 code for Sarcopenia. J Cachexia Sarcopenia Muscle. 2016;7(5):512–4.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Chien MY, Huang TY, Wu YT. Prevalence of Sarcopenia estimated using a bioelectrical impedance analysis prediction equation in community-dwelling elderly people in Taiwan. J Am Geriatr Soc. 2008;56(9):1710–5.

    Article  PubMed  Google Scholar 

  25. Wang S, Xie H, Gong Y, Kuang J, Yan L, Ruan G, Gao F, Gan J. The value of L3 skeletal muscle index in evaluating preoperative nutritional risk and long-term prognosis in colorectal cancer patients. Sci Rep. 2020;10(1):8153.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Austin PC. Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies. Pharm Stat. 2011;10(2):150–61.

    Article  PubMed  Google Scholar 

  27. Lin JA, Liao CC, Chang CC, Chang H, Chen TL. Postoperative adverse outcomes in intellectually disabled surgical patients: a nationwide population-based study. PLoS ONE. 2011;6(10):e26977.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Lin JA, Liao CC, Lee YJ, Wu CH, Huang WQ, Chen TL. Adverse outcomes after major surgery in patients with systemic lupus erythematosus: a nationwide population-based study. Ann Rheum Dis. 2014;73(9):1646–51.

    Article  PubMed  Google Scholar 

  29. Liao CC, Shen WW, Chang CC, Chang H, Chen TL. Surgical adverse outcomes in patients with schizophrenia: a population-based study. Ann Surg. 2013;257(3):433–8.

    Article  PubMed  Google Scholar 

  30. Ghaferi AA, Birkmeyer JD, Dimick JB. Variation in hospital mortality associated with inpatient surgery. N Engl J Med. 2009;361(14):1368–75.

    Article  CAS  PubMed  Google Scholar 

  31. Khuri SF, Henderson WG, DePalma RG, Mosca C, Healey NA, Kumbhani DJ. Participants in the VANSQIP: determinants of long-term survival after major surgery and the adverse effect of postoperative complications. Ann Surg. 2005;242(3):326–41. discussion 341 – 323.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Chang CC, Hu CJ, Lam F, Chang H, Liao CC, Chen TL. Postoperative adverse outcomes in surgical patients with epilepsy: a population-based study. Epilepsia. 2012;53(6):987–94.

    Article  PubMed  Google Scholar 

  33. Austin PC. The performance of different propensity score methods for estimating marginal hazard ratios. Stat Med. 2013;32(16):2837–49.

    Article  PubMed  Google Scholar 

  34. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205–13.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Qin L, Chen TM, Kao YW, Lin KC, Yuan KS, Wu ATH, Shia BC, Wu SY. Predicting 90-Day mortality in Locoregionally Advanced Head and Neck Squamous Cell Carcinoma after curative surgery. Cancers (Basel) 2018, 10(10).

  36. Lin KC, Chen TM, Yuan KS, Wu ATH, Wu SY. Assessment of Predictive Scoring System for 90-Day mortality among patients with locally Advanced Head and Neck squamous cell Carcinoma who have completed concurrent chemoradiotherapy. JAMA Netw Open. 2020;3(3):e1920671.

    Article  PubMed  Google Scholar 

  37. Shia BC, Qin L, Lin KC, Fang CY, Tsai LL, Kao YW, Wu SY. Age comorbidity scores as risk factors for 90-day mortality in patients with a pancreatic head adenocarcinoma receiving a pancreaticoduodenectomy: a National Population-based study. Cancer Med. 2020;9(2):562–74.

    Article  PubMed  Google Scholar 

  38. Pugalenthi A, Protic M, Gonen M, Kingham TP, Angelica MI, Dematteo RP, Fong Y, Jarnagin WR, Allen PJ. Postoperative complications and overall survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma. J Surg Oncol. 2016;113(2):188–93.

    Article  PubMed  Google Scholar 

  39. Mise Y, Vauthey JN, Zimmitti G, Parker NH, Conrad C, Aloia TA, Lee JE, Fleming JB, Katz MH. Ninety-day postoperative mortality is a legitimate measure of Hepatopancreatobiliary Surgical Quality. Ann Surg. 2015;262(6):1071–8.

    Article  PubMed  Google Scholar 

  40. Lieffers JR, Bathe OF, Fassbender K, Winget M, Baracos VE. Sarcopenia is associated with postoperative infection and delayed recovery from colorectal cancer resection surgery. Br J Cancer. 2012;107(6):931–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Yang TR, Luo K, Deng X, Xu L, Wang RR, Ji P, Brittany, Park, et al. Consensus-defined Sarcopenia predicts adverse outcomes after elective abdominal surgery: meta-analysis. World J Emerg Surg. 2022;17(1):36.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Lobo DN, Gianotti L, Adiamah A, Barazzoni R, Deutz NEP, Dhatariya K, Greenhaff PL, Hiesmayr M, Hjort Jakobsen D, Klek S, et al. Perioperative nutrition: recommendations from the ESPEN expert group. Clin Nutr. 2020;39(11):3211–27.

    Article  CAS  PubMed  Google Scholar 

  43. Ansaripour A, Arjomandi Rad A, Koulouroudias M, Angouras D, Athanasiou T, Kourliouros A. Sarcopenia adversely affects outcomes following cardiac surgery: a systematic review and Meta-analysis. J Clin Med 2023, 12(17).

  44. Park B, Bhat S, Xia W, Barazanchi AWH, Frampton C, Hill AG, MacCormick AD. Consensus-defined Sarcopenia predicts adverse outcomes after elective abdominal surgery: meta-analysis. BJS Open 2023, 7(4).

  45. Shen Y, Hao Q, Zhou J, Dong B. The impact of frailty and sarcopenia on postoperative outcomes in older patients undergoing gastrectomy surgery: a systematic review and meta-analysis. BMC Geriatr. 2017;17(1):188.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Wahlen BM, Mekkodathil A, Al-Thani H, El-Menyar A. Impact of Sarcopenia in trauma and surgical patient population: a literature review. Asian J Surg. 2020;43(6):647–53.

    Article  PubMed  Google Scholar 

  47. Roubenoff R. Sarcopenia and its implications for the elderly. Eur J Clin Nutr. 2000;54(Suppl 3):S40–47.

    Article  PubMed  Google Scholar 

  48. Yuan H, Goto N, Akita H, Shiraishi N, He HJ. Morphometric analysis of the human cervical motoneurons in the aging process. Okajimas Folia Anat Jpn. 2000;77(1):1–4.

    Article  CAS  PubMed  Google Scholar 

  49. Hirase T, Haghshenas V, Bratescu R, Dong D, Kuo PH, Rashid A, Kavuri V, Hanson DS, Meyer BC, Marco RAW. Sarcopenia predicts perioperative adverse events following complex revision surgery for the thoracolumbar spine. Spine J. 2021;21(6):1001–9.

    Article  PubMed  Google Scholar 

  50. Flexman AM, Street J, Charest-Morin R. The impact of frailty and sarcopenia on patient outcomes after complex spine surgery. Curr Opin Anaesthesiol. 2019;32(5):609–15.

    Article  PubMed  Google Scholar 

  51. Charest-Morin R, Street J, Zhang H, Roughead T, Ailon T, Boyd M, Dvorak M, Kwon B, Paquette S, Dea N, et al. Frailty and Sarcopenia do not predict adverse events in an elderly population undergoing non-complex primary elective surgery for degenerative conditions of the lumbar spine. Spine J. 2018;18(2):245–54.

    Article  PubMed  Google Scholar 

  52. Yamashita S, Iguchi T, Koike H, Wakamiya T, Kikkawa K, Kohjimoto Y, Hara I. Impact of preoperative Sarcopenia and myosteatosis on prognosis after radical cystectomy in patients with bladder cancer. Int J Urol. 2021;28(7):757–62.

    Article  PubMed  Google Scholar 

  53. Kobayashi A, Kaido T, Hamaguchi Y, Okumura S, Shirai H, Yao S, Kamo N, Yagi S, Taura K, Okajima H, et al. Impact of sarcopenic obesity on outcomes in patients undergoing hepatectomy for Hepatocellular Carcinoma. Ann Surg. 2019;269(5):924–31.

    Article  PubMed  Google Scholar 

  54. Antoniou GA, Rojoa D, Antoniou SA, Alfahad A, Torella F, Juszczak MT. Effect of low skeletal muscle Mass on post-operative survival of patients with abdominal aortic aneurysm: a prognostic factor review and Meta-analysis of Time-to-Event Data. Eur J Vasc Endovasc Surg. 2019;58(2):190–8.

    Article  PubMed  Google Scholar 

  55. Stone L, Olson B, Mowery A, Krasnow S, Jiang A, Li R, Schindler J, Wax MK, Andersen P, Marks D, et al. Association between Sarcopenia and Mortality in patients undergoing Surgical Excision of Head and Neck Cancer. JAMA Otolaryngol Head Neck Surg. 2019;145(7):647–54.

    Article  PubMed  PubMed Central  Google Scholar 

  56. Mokart D, Giaoui E, Barbier L, Lambert J, Sannini A, Chow-Chine L, Brun JP, Faucher M, Guiramand J, Ewald J, et al. Postoperative sepsis in cancer patients undergoing major elective digestive surgery is associated with increased long-term mortality. J Crit Care. 2016;31(1):48–53.

    Article  PubMed  Google Scholar 

  57. Ou L, Chen J, Hillman K, Flabouris A, Parr M, Assareh H, Bellomo R. The impact of post-operative sepsis on mortality after hospital discharge among elective surgical patients: a population-based cohort study. Crit Care. 2017;21(1):34.

    Article  PubMed  PubMed Central  Google Scholar 

  58. Chen PY, Luo CW, Chen MH, Yang ML, Kuan YH. Epidemiological characteristics of postoperative Sepsis. Open Med (Wars). 2019;14:928–38.

    Article  PubMed  Google Scholar 

  59. Flanagan JM, Read C, Shindul-Rothschild J. Factors Associated with the rate of Sepsis after surgery. Crit Care Nurse. 2020;40(5):e1–9.

    Article  PubMed  Google Scholar 

  60. Lutz CT, Quinn LS. Sarcopenia, obesity, and natural killer cell immune senescence in aging: altered cytokine levels as a common mechanism. Aging. 2012;4(8):535–46.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  61. Rong YD, Bian AL, Hu HY, Ma Y, Zhou XZ. Study on relationship between elderly Sarcopenia and inflammatory cytokine IL-6, anti-inflammatory cytokine IL-10. BMC Geriatr. 2018;18(1):308.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  62. Pedersen BK, Febbraio MA. Muscle as an endocrine organ: focus on muscle-derived interleukin-6. Physiol Rev. 2008;88(4):1379–406.

    Article  CAS  PubMed  Google Scholar 

  63. Imierska M, Kurianiuk A, Blachnio-Zabielska A. The influence of physical activity on the bioactive lipids metabolism in obesity-Induced muscle insulin resistance. Biomolecules 2020, 10(12).

  64. Andrews FJ, Griffiths RD. Glutamine: essential for immune nutrition in the critically ill. Br J Nutr. 2002;87(Suppl 1):S3–8.

    Article  CAS  PubMed  Google Scholar 

  65. Torrance HDT, Longbottom ER, Vivian ME, Lalabekyan B, Abbott TEF, Ackland GL, Hinds CJ, Pearse RM, O’Dwyer MJ. Post-operative immune suppression is mediated via reversible, Interleukin-10 dependent pathways in circulating monocytes following major abdominal surgery. PLoS ONE. 2018;13(9):e0203795.

    Article  PubMed  PubMed Central  Google Scholar 

  66. Okazaki T, Ebihara S, Mori T, Izumi S, Ebihara T. Association between Sarcopenia and pneumonia in older people. Geriatr Gerontol Int. 2020;20(1):7–13.

    Article  PubMed  Google Scholar 

  67. Ebihara S, Sekiya H, Miyagi M, Ebihara T, Okazaki T. Dysphagia, dystussia, and aspiration pneumonia in elderly people. J Thorac Dis. 2016;8(3):632–9.

    Article  PubMed  PubMed Central  Google Scholar 

  68. Soma D, Kawamura YI, Yamashita S, Wake H, Nohara K, Yamada K, Kokudo N. Sarcopenia, the depletion of muscle mass, an independent predictor of respiratory complications after oncological esophagectomy. Dis Esophagus 2019, 32(3).

  69. Jain R, Handorf E, Khare V, Blau M, Chertock Y, Hall MJ. Impact of Baseline Nutrition and Exercise Status on Toxicity and outcomes in Phase I and II oncology clinical trial participants. Oncologist. 2020;25(2):161–9.

    Article  PubMed  Google Scholar 

  70. Lee DU, Fan GH, Hastie DJ, Addonizio EA, Suh J, Prakasam VN, Karagozian R. The clinical impact of malnutrition on the postoperative outcomes of patients undergoing colorectal resection surgery for colon or rectal cancer: propensity score matched analysis of 2011–2017 US hospitals. Surg Oncol. 2021;38:101587.

    Article  PubMed  Google Scholar 

  71. Lee DU, Hastie DJ, Fan GH, Addonizio EA, Lee KJ, Han J, Karagozian R. Effect of malnutrition on the postoperative outcomes of patients undergoing pancreatectomy for pancreatic cancer: Propensity score-matched analysis of 2011–2017 US hospitals. Nutr Clin Pract. 2022;37(1):117–29.

    Article  PubMed  Google Scholar 

Download references

Funding

The work of Szu-Yuan Wu is supported by the Lo-Hsu Medical Foundation, Lotung Poh-Ai Hospital, under funding numbers 11001, 11010, 11013, and 11103 and the work of Jiaqiang Zhang is supported by the National Key Research and Development Program of China,under funding number 2023YFC2506903.

Author information

Author notes

  1. Yitian Yang and Mingyang Sun have contributed equally to this study (joint primary authors).

  2. Szu-Yuan Wu and Jiaqiang Zhang have contributed equally to this study (joint Correspondence authors).

Authors and Affiliations

  1. Department of Anesthesiology and Perioperative Medicine, Henan Provincial People’s Hospital, People’s Hospital of Zhengzhou University, Zhengzhou, China

    Yitian Yang, Mingyang Sun & Jiaqiang Zhang

  2. Graduate Institute of Business Administration, College of Management, Fu Jen Catholic University, Taipei, Taiwan

    Wan-Ming Chen & Szu-Yuan Wu

  3. Artificial Intelligence Development Center, Fu Jen Catholic University, Taipei, Taiwan

    Wan-Ming Chen & Szu-Yuan Wu

  4. Department of Food Nutrition and Health Biotechnology, College of Medical and Health Science, Asia University, Taichung, Taiwan

    Szu-Yuan Wu

  5. Big Data Center, Lo-Hsu Medical Foundation, Lotung Poh-Ai Hospital, Yilan, Taiwan

    Szu-Yuan Wu

  6. Division of Radiation Oncology, Lo-Hsu Medical Foundation, Lotung Poh-Ai Hospital, Yilan, Taiwan

    Szu-Yuan Wu

  7. Department of Healthcare Administration, College of Medical and Health Science, Asia University, Taichung, Taiwan

    Szu-Yuan Wu

  8. Cancer Center, Lo-Hsu Medical Foundation, Lotung Poh-Ai Hospital, Yilan, Taiwan

    Szu-Yuan Wu

  9. Centers for Regional Anesthesia and Pain Medicine, Taipei Municipal Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan

    Szu-Yuan Wu

  10. Department of Management, College of Management, Fo Guang University, Yilan, Taiwan

    Szu-Yuan Wu

Authors
  1. Yitian Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mingyang Sun
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Wan-Ming Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Szu-Yuan Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jiaqiang Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

The collaborative effort of the authors resulted in the conception and design of the study, led by Yitian Yang, Mingyang Sun, Wan-Ming Chen, Szu-Yuan Wu, and Jiaqiang Zhang. Financial support for this work was provided by the Lo-Hsu Medical Foundation, Lotung Poh-Ai Hospital, with funding numbers 11001, 11010, 11013, and 11103, benefiting the research of Szu-Yuan Wu. The comprehensive collection and assembly of data were carried out by Yitian Yang, Szu-Yuan Wu, and Jiaqiang Zhang. The crucial tasks of data analysis and interpretation were undertaken by Jiaqiang Zhang and Szu-Yuan Wu. Administrative support was provided by Szu-Yuan Wu. The manuscript itself was written collaboratively by Yitian Yang, Mingyang Sun, Wan-Ming Chen, Szu-Yuan Wu, and Jiaqiang Zhang. Lastly, the final approval of the manuscript was granted by all authors, reflecting their unified contributions and dedication to the study’s completion.

Corresponding authors

Correspondence to Szu-Yuan Wu or Jiaqiang Zhang.

Ethics declarations

Competing interests

The authors, Yitian Yang, Mingyang Sun, Wan-Ming Chen, Szu-Yuan Wu, and Jiaqiang Zhang, declare no potential conflicts of interest in relation to the research, its execution, or its publication.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary Material 1

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yang, Y., Sun, M., Chen, WM. et al. Adverse postoperative outcomes in elderly patients with sarcopenia. BMC Geriatr 24, 561 (2024). https://doi.org/10.1186/s12877-024-05066-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12877-024-05066-2

Keywords

BMC Geriatrics

ISSN: 1471-2318

Contact us